Daxor Corporation (NASDAQ: DXR) Stock Information | RedChip

Daxor Corporation (NASDAQ: DXR) Listen to this Section


$8.89
-0.1100 ( -1.22% ) 0.0K

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Market Data


Open


$8.89

Previous close


$9.00

Volume


0.0K

Market cap


$43.53M

Day range


$8.61 - $9.00

52 week range


$7.11 - $10.04

Insider Ownership Transactions

Total Amount Purchased: -6,650.00 | $ -59,118.50

Date Type Amount Purchased Purchaser
2024-07-17 Sale -2500.00 Cremisi Henry D.
2024-07-17 Sale -2500.00 Feuer Edward
2024-07-17 Sale -2500.00 Goudie Joy S.
2024-07-17 Sale -2500.00 DesRosiers Caleb
2024-03-27 Buy 750.00 Michel Robert J
2024-03-06 Buy 1000.00 Feuer Edward
2023-12-06 Buy 120.00 Michel Robert J
2023-12-01 Buy 800.00 Feldschuh Michael Richard
2023-12-01 Buy 180.00 Michel Robert J
2023-11-27 Buy 500.00 Michel Robert J

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Jul 18, 2024
4 Insider transactions 1 Jul 17, 2024
4 Insider transactions 1 Jul 17, 2024
4 Insider transactions 1 Jul 17, 2024
4 Insider transactions 1 Jul 17, 2024
def Proxies and info statements 1 Jun 21, 2024
8-k 8K-related 13 Jun 05, 2024
nport-p Other 1 May 30, 2024
4 Insider transactions 1 Mar 27, 2024
8-k 8K-related 15 Mar 25, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.